Research Review
From Medical Device to Consumer Gadget
Continuous glucose monitors were designed for people with diabetes. For decades, they served a single purpose: helping patients manage blood sugar levels that their bodies could not regulate on their own. The devices were prescription-only, expensive, and not particularly comfortable to wear.
That landscape shifted dramatically in 2024 and 2025. Abbott launched the Lingo, a consumer-oriented CGM available over the counter for $49 to start. Dexcom followed with the Stelo, also available without a prescription. Suddenly, anyone with curiosity and a credit card could see their glucose levels in real time, 24 hours a day, through a small sensor stuck to the back of their arm.
The question is no longer whether non-diabetic people can use CGMs. It is whether they should.
What a CGM Actually Measures
A CGM measures interstitial glucose: the glucose concentration in the fluid between your cells. This is not the same as blood glucose, though the two track closely with a lag of about 5 to 15 minutes. A tiny filament sits just below the skin surface and takes a reading every 1 to 5 minutes depending on the device.
The result is a continuous glucose curve that shows you exactly how your body responds to food, exercise, stress, sleep, and dozens of other variables. Instead of a single fasting blood sugar number from an annual physical, you get a constant stream of data that reveals patterns no snapshot test can capture.
For someone with diabetes, this information is medically essential. For everyone else, the value depends entirely on what you do with it.
The Case for CGMs in Athletes and Active People
The strongest argument for non-diabetic CGM use centers on individual variation. Two people can eat the exact same meal and produce wildly different glucose responses. A bowl of oatmeal that barely registers for one person might spike another person's glucose by 60 mg/dL. A banana before a workout might fuel one athlete perfectly while leaving another sluggish from a reactive blood sugar drop.
A landmark study published in Cell by Zeevi and colleagues tracked 800 participants with continuous glucose monitoring and found that individual glycemic responses to identical foods varied enormously. Their machine learning model, trained on personal CGM data, predicted individual glucose responses far more accurately than any standard nutritional index like glycemic index or carbohydrate counting.
CGM data reveals these individual patterns in ways that generalized nutrition advice cannot:
- Pre-workout fuel optimization. Athletes can identify which carbohydrate sources produce stable energy versus sharp spikes followed by crashes. This is particularly relevant for endurance athletes who need sustained energy output over hours.
- Post-workout recovery nutrition. Glucose responses to post-workout meals can indicate how effectively your body is replenishing glycogen stores. A blunted response after hard training may signal improved insulin sensitivity from the session.
- Sleep quality correlations. Nocturnal glucose dips and spikes correlate with sleep disruption. Some users discover that eating certain foods close to bedtime causes overnight glucose instability that fragments their sleep.
- Stress and cortisol effects. Glucose can rise significantly during periods of psychological stress even without eating. Seeing this in real time helps athletes understand how non-training stressors affect their physiology.
The Case Against (for Most People)
The enthusiasm around consumer CGMs has outpaced the evidence for most of the claimed benefits. Several important limitations deserve honest consideration.
Metabolically healthy people have less to gain. If your fasting glucose is normal, your HbA1c is in range, and you are physically active, your glucose regulation is already working well. The patterns a CGM reveals may be interesting, but they are unlikely to change your health outcomes meaningfully. You are optimizing a system that is already functioning properly.
The cost adds up quickly. Consumer CGMs range from $49 to $299 per month depending on the platform and coaching tier. Over a year, that is $600 to $3,600 spent on monitoring a single biomarker. For most healthy individuals, that budget would produce better outcomes if spent on higher-quality food, a gym membership, or a well-designed training program.
Data anxiety is real. Continuous monitoring can create a hypervigilant relationship with food where every glucose rise triggers concern. Post-meal glucose spikes are a normal physiological response. Glucose rising to 140 or 150 mg/dL after eating is not pathological in a healthy person, but the graph on your phone can make it feel that way. Some users report increased food anxiety after starting CGM use, which is counterproductive to overall well-being.
Accuracy has limits. Even the best consumer CGMs have a Mean Absolute Relative Difference (MARD) of 7.9 to 9.3%. That means readings can be off by roughly 8 to 9% in either direction. For someone with normal glucose levels, a reading of 100 mg/dL could actually be anywhere from 91 to 109. At this margin, many of the "spikes" people react to may be measurement noise rather than real metabolic signals.
The 2026 Consumer CGM Landscape
The market has expanded rapidly. Here is where the major options stand:
- Abbott Lingo: the most affordable entry point at $49 initial cost plus $91 per month. Includes AI-powered habit coaching and no prescription requirement.
- Dexcom Stelo: $55 initial plus $89 per month. Over-the-counter availability with 8.3% MARD accuracy. FDA-cleared for general wellness use.
- Ultrahuman M1: premium option at $299 per month with live coaching. Targeted at performance-focused athletes who want the most actionable interpretation of their data.
- Levels Health: $24 per month app membership with sensor purchased separately. Popular among data-driven biohackers for its analytics dashboard and food scoring system.
- Nutrisense: $149 per month with 1-on-1 dietitian support. Best suited for people who want professional guidance interpreting their glucose patterns.
All major services now accept HSA and FSA payments, which reduces the effective cost for many users.
When CGM Data Meets the Rest of Your Health Stack
The most compelling use case for CGMs in non-diabetic populations is not the glucose data alone. It is what happens when that data connects with everything else: sleep quality, HRV, training load, nutrition intake, and recovery trends.
In isolation, a glucose spike after lunch is just a number. But combined with the knowledge that you slept poorly last night (research shows a single night of short sleep can reduce insulin sensitivity by 25 to 30% in otherwise healthy adults), trained hard this morning (which improves insulin sensitivity), and ate 30 grams fewer protein than your target (which affects the glucose response to carbohydrates), the same spike tells a much richer story.
This is where platforms like Vora add value beyond single-metric monitoring. Rather than tracking glucose in one app, sleep in another, training in a third, and nutrition in a fourth, an integrated system can surface correlations that no single data stream reveals on its own. Your nutrition logging, recovery data, and training load all feed into the same coaching engine, which means the AI can identify patterns like "your glucose control is worse on days after poor sleep" or "your recovery improves when you avoid high-glycemic meals close to bedtime."
For most people, tracking nutrition, sleep, training, and recovery through an integrated platform will deliver more actionable insights than a CGM alone. But for those who do use a CGM, the data becomes significantly more valuable when it is not sitting in a silo.
The Bottom Line
CGMs are genuinely useful tools for the right person. If you are an endurance athlete optimizing pre-competition fueling, a biohacker running structured experiments on metabolic health, or someone with prediabetes using data to guide dietary changes, a CGM can provide insights that are difficult to get any other way.
If you are a generally healthy, active person who eats reasonably well and wants to improve your fitness, a CGM is probably not the highest-return investment you can make. The fundamentals (consistent training, adequate protein, quality sleep, and stress management) will move the needle far more than real-time glucose monitoring, and they cost less.
The best health tracking setup is one where all your data works together. Whether that includes a CGM or not, the goal is the same: actionable information that changes your behavior for the better.